S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
$0.05
$0.06
$0.05
$0.22
N/AN/A5,680 shsN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$62.21
-0.8%
$70.61
$51.79
$89.91
$9.78B1.221.07 million shs1.17 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
0.00%-22.58%-20.03%-21.53%-31.99%
Bio-Techne Co. stock logo
TECH
Bio-Techne
-2.00%-9.75%-12.73%-10.21%-25.61%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/AN/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.9762 of 5 stars
4.42.01.74.22.92.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
2.78
Moderate Buy$83.9034.87% Upside

Current Analyst Ratings

Latest DFX, TECH, CBUY, OCQLF, and OU1 Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$85.00 ➝ $82.00
2/8/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$80.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$92.00 ➝ $87.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$85.00 ➝ $75.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$65.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$1.14B8.60$2.45 per share25.44$12.49 per share4.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/A0.00N/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$285.26M$1.3845.0834.187.2419.58%14.21%10.36%5/1/2024 (Confirmed)

Latest DFX, TECH, CBUY, OCQLF, and OU1 Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.40N/A-$0.40N/AN/AN/A  
2/1/2024Q2 2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.36$0.33-$0.03$0.49$277.48 million$272.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.320.51%+151.98%23.19%N/A

Latest DFX, TECH, CBUY, OCQLF, and OU1 Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
quarterly$0.080.5%2/9/20242/12/20242/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
0.23
4.37
3.03

Ownership

Institutional Ownership

CompanyInstitutional Ownership
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.45%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
01 Communique Laboratory Inc. stock logo
OCQLF
01 Communique Laboratory
N/AN/AN/ANot Optionable
Bio-Techne Co. stock logo
TECH
Bio-Techne
3,050157.19 million150.20 millionOptionable

DFX, TECH, CBUY, OCQLF, and OU1 Headlines

SourceHeadline
Navigating 4 Analyst Ratings For Bio-TechneNavigating 4 Analyst Ratings For Bio-Techne
markets.businessinsider.com - April 18 at 2:43 PM
Bio-Techne (NASDAQ:TECH) Price Target Cut to $82.00 by Analysts at Deutsche Bank AktiengesellschaftBio-Techne (NASDAQ:TECH) Price Target Cut to $82.00 by Analysts at Deutsche Bank Aktiengesellschaft
marketbeat.com - April 18 at 8:35 AM
Bio-Techne Co. (NASDAQ:TECH) Shares Purchased by Cerity Partners LLCBio-Techne Co. (NASDAQ:TECH) Shares Purchased by Cerity Partners LLC
marketbeat.com - April 18 at 5:39 AM
SVB Wealth LLC Sells 25,151 Shares of Bio-Techne Co. (NASDAQ:TECH)SVB Wealth LLC Sells 25,151 Shares of Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 17 at 7:51 AM
Mackenzie Financial Corp Boosts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)Mackenzie Financial Corp Boosts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 16 at 9:27 AM
WCM Investment Management LLC Makes New $1.02 Million Investment in Bio-Techne Co. (NASDAQ:TECH)WCM Investment Management LLC Makes New $1.02 Million Investment in Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 15 at 7:31 AM
Healthcare offers diversification from market hot spotsHealthcare offers diversification from market hot spots
livewiremarkets.com - April 14 at 11:26 PM
Cell Culture Market worth $57.9 billion by 2029 | MarketsandMarkets™Cell Culture Market worth $57.9 billion by 2029 | MarketsandMarkets™
theglobeandmail.com - April 12 at 9:51 AM
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTSBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
prnewswire.com - April 10 at 7:00 AM
New York State Teachers Retirement System Reduces Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)New York State Teachers Retirement System Reduces Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 10 at 5:35 AM
Allspring Global Investments Holdings LLC Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH)Allspring Global Investments Holdings LLC Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 9 at 9:55 AM
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGYBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
prnewswire.com - April 8 at 7:00 AM
Riverbridge Partners LLC Sells 15,014 Shares of Bio-Techne Co. (NASDAQ:TECH)Riverbridge Partners LLC Sells 15,014 Shares of Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 5 at 12:58 AM
Buy Rating Affirmed for Bio-Techne Amid Market Recovery and Strategic PositioningBuy Rating Affirmed for Bio-Techne Amid Market Recovery and Strategic Positioning
markets.businessinsider.com - April 4 at 12:26 PM
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial ExcellenceBio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
seekingalpha.com - April 4 at 8:43 AM
RedShiftBio Welcomes Sebastian Arevalo as New Sales LeaderRedShiftBio Welcomes Sebastian Arevalo as New Sales Leader
msn.com - April 3 at 1:35 PM
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCEBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
finance.yahoo.com - April 3 at 8:34 AM
Bio-Techne (NASDAQ:TECH) shareholders have earned a 7.4% CAGR over the last five yearsBio-Techne (NASDAQ:TECH) shareholders have earned a 7.4% CAGR over the last five years
finance.yahoo.com - April 1 at 9:04 AM
BIO-TECHNE RECEIVES CiteAbS ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDSBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
finance.yahoo.com - April 1 at 9:04 AM
Raymond James & Associates Boosts Stake in Bio-Techne Co. (NASDAQ:TECH)Raymond James & Associates Boosts Stake in Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - April 1 at 4:24 AM
Bio-Techne Co. (NASDAQ:TECH) Shares Bought by Assenagon Asset Management S.A.Bio-Techne Co. (NASDAQ:TECH) Shares Bought by Assenagon Asset Management S.A.
marketbeat.com - March 30 at 4:50 AM
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICESBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
prnewswire.com - March 28 at 9:00 AM
Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their ApplicationsGlobal Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications
finance.yahoo.com - March 27 at 10:45 AM
Fort Washington Investment Advisors Inc. OH Purchases 19,390 Shares of Bio-Techne Co. (NASDAQ:TECH)Fort Washington Investment Advisors Inc. OH Purchases 19,390 Shares of Bio-Techne Co. (NASDAQ:TECH)
marketbeat.com - March 26 at 11:09 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

01 Communique Laboratory logo

01 Communique Laboratory

OTCMKTS:OCQLF
01 Communique Laboratory, Inc. develops and markets remote access solutions. The Company's solutions consist of I'm InTouch, I'm OnCall and I'm InTouch Meeting product lines, which provide users with the ability to conduct online meetings. 01 Communique Laboratory was founded on October 7, 1992 and is headquartered in Toronto, Canada.
Bio-Techne logo

Bio-Techne

NASDAQ:TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.